# EDGAR Filing Document

**Accession Number:** 0001842952
**File Stem:** 0001842952-23-000022
**Filing Date:** 2023-2
**Character Count:** 25398
**Document Hash:** 2972f8c8b02026cefae715edbe58c8bf
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001842952-23-000022.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001842952-23-000022

**CONFORMED SUBMISSION TYPE**: SC 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Context Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0001842952
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 863738787
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93112
- **FILM NUMBER:** 23628621

**BUSINESS ADDRESS:**
- **STREET 1:** 2001 MARKET STREET
- **STREET 2:** SUITE 3915 UNIT #15
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103
- **BUSINESS PHONE:** 267-225-7416

**MAIL ADDRESS:**
- **STREET 1:** 2001 MARKET STREET
- **STREET 2:** SUITE 3915 UNIT #15
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Context Therapeutics LLC
- **DATE OF NAME CHANGE:** 20210128
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Context Therapeutics Inc.
- **CENTRAL INDEX KEY:** 0001842952
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 863738787
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G

**BUSINESS ADDRESS:**
- **STREET 1:** 2001 MARKET STREET
- **STREET 2:** SUITE 3915 UNIT #15
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103
- **BUSINESS PHONE:** 267-225-7416

**MAIL ADDRESS:**
- **STREET 1:** 2001 MARKET STREET
- **STREET 2:** SUITE 3915 UNIT #15
- **CITY:** PHILADELPHIA
- **STATE:** PA
- **ZIP:** 19103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Context Therapeutics LLC
- **DATE OF NAME CHANGE:** 20210128

---

| |
|:---|
| **UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION**<br>**Washington, D.C. 20549** |
| **SCHEDULE 13G**<br>**Under the Securities Exchange Act of 1934**<br>**(Amendment No. ___)\*** |
| Context Therapeutics Inc. |
| <sup>(Name of Issuer)</sup><br>Common Stock, par value $0.001 per share |
| <sup>(Title of Class of Securities)</sup><br>21077P108 |
| <sup>(CUSIP Number)</sup><br>December 31, 2022 |
| &nbsp;&nbsp;(Date of Event Which Requires Filing of this Statement) |

---

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

&nbsp;&nbsp;&nbsp;&nbsp;☐ Rule 13d-1(b)

&nbsp;&nbsp;&nbsp;&nbsp;☐ Rule 13d-1(c)

&nbsp;&nbsp;&nbsp;&nbsp;☒ Rule 13d-1(d)

\*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(continued on the following pages)

------

---

| | |
|:---|:---|
| **CUSIP No. 21077P108** | **13G** |

---

---

| | | | |
|:---|:---|:---|:---|
| **1** | NAMES OF REPORTING PERSONS<br>&nbsp;&nbsp;&nbsp;&nbsp;Martin Lehr | NAMES OF REPORTING PERSONS<br>&nbsp;&nbsp;&nbsp;&nbsp;Martin Lehr | NAMES OF REPORTING PERSONS<br>&nbsp;&nbsp;&nbsp;&nbsp;Martin Lehr |
| **2** | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  |
| **3** | SEC USE ONLY | SEC USE ONLY | SEC USE ONLY |
| **4** | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;United States | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;United States | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;United States |
| <br>NUMBER OF | <br>NUMBER OF | **5** | SOLE VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;365,912 (1) |
| SHARES<br>BENEFICIALLY<br>OWNED BY | SHARES<br>BENEFICIALLY<br>OWNED BY | **6** | SHARED VOTING POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190 (2)  |
| EACH<br>REPORTING<br>PERSON | EACH<br>REPORTING<br>PERSON | **7** | SOLE DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;365,912 (1) |
| WITH: | WITH: | **8** | SHARED DISPOSITIVE POWER<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190 (2) |
| **9** | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;1,186,102 (1)(2) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;1,186,102 (1)(2) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;1,186,102 (1)(2) |
| **10** | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A |
| **11** | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;7.3% (1)(2)(3) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;7.3% (1)(2)(3) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;7.3% (1)(2)(3) |
| **12** | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;IN | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;IN | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;IN |

---

**________**

(1) Consists of (i) 243,329 shares of the Issuer's common stock underlying options held directly by Mr. Lehr that are exercisable within 60 days of December 31, 2022 (the "Option Shares") and (ii) 122,583 shares of the Issuer's common stock held directly by Mr. Lehr.

(2) Represents shares of the Issuer's common stock held by the Martin Lehr 2000 Trust.

(3) Based upon 15,966,053 shares of the Issuer's common stock outstanding as of November 4, 2022, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2022, plus the Option Shares.

------

---

| | |
|:---|:---|
| **CUSIP No. 21077P108** | **13G** |

---

---

| | | | |
|:---|:---|:---|:---|
| **1** | NAMES OF REPORTING PERSONS<br>Martin Lehr 2000 Trust | NAMES OF REPORTING PERSONS<br>Martin Lehr 2000 Trust | NAMES OF REPORTING PERSONS<br>Martin Lehr 2000 Trust |
| **2** | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  |
| **3** | SEC USE ONLY | SEC USE ONLY | SEC USE ONLY |
| **4** | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania |
| <br>NUMBER OF | <br>NUMBER OF | **5** | SOLE VOTING POWER<br>0 |
| SHARES<br>BENEFICIALLY<br>OWNED BY | SHARES<br>BENEFICIALLY<br>OWNED BY | **6** | SHARED VOTING POWER<br>820,190 |
| EACH<br>REPORTING<br>PERSON | EACH<br>REPORTING<br>PERSON | **7** | SOLE DISPOSITIVE POWER<br>0 |
| WITH: | WITH: | **8** | SHARED DISPOSITIVE POWER<br>820,190 |
| **9** | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190  | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190  | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190  |
| **10** | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A |
| **11** | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;5.1% (1) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;5.1% (1) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;5.1% (1) |
| **12** | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;OO | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;OO | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;OO |

---

**________**

(1) Based upon 15,966,053 shares of the Issuer's common stock outstanding as of November 4, 2022, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2022.

------

---

| | |
|:---|:---|
| **CUSIP No. 21077P108** | **13G** |

---

---

| | | | |
|:---|:---|:---|:---|
| **1** | NAMES OF REPORTING PERSONS<br>Ellyn Lehr | NAMES OF REPORTING PERSONS<br>Ellyn Lehr | NAMES OF REPORTING PERSONS<br>Ellyn Lehr |
| **2** | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)<br>(a) ☐ <br>&nbsp;&nbsp;&nbsp;&nbsp;<br>(b) ☒  |
| **3** | SEC USE ONLY | SEC USE ONLY | SEC USE ONLY |
| **4** | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania | CITIZENSHIP OR PLACE OF ORGANIZATION<br>&nbsp;&nbsp;&nbsp;&nbsp;Pennsylvania |
| <br>NUMBER OF | <br>NUMBER OF | **5** | SOLE VOTING POWER<br>0 |
| SHARES<br>BENEFICIALLY<br>OWNED BY | SHARES<br>BENEFICIALLY<br>OWNED BY | **6** | SHARED VOTING POWER<br>820,190 (1) |
| EACH<br>REPORTING<br>PERSON | EACH<br>REPORTING<br>PERSON | **7** | SOLE DISPOSITIVE POWER<br>0 |
| WITH: | WITH: | **8** | SHARED DISPOSITIVE POWER<br>820,190 (1) |
| **9** | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190 (1) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190 (1) | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>&nbsp;&nbsp;&nbsp;&nbsp;820,190 (1) |
| **10** | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) <br>&nbsp;&nbsp;&nbsp;&nbsp;N/A |
| **11** | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;5.1% (1)(2) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;5.1% (1)(2) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)<br>&nbsp;&nbsp;&nbsp;&nbsp;5.1% (1)(2) |
| **12** | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;IN | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;IN | TYPE OF REPORTING PERSON (See Instructions)<br>&nbsp;&nbsp;&nbsp;&nbsp;IN |

---

**________**

(1) Represents shares of the Issuer's common stock held by the Martin Lehr 2000 Trust.

(2) Based upon 15,966,053 shares of the Issuer's common stock outstanding as of November 4, 2022, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2022.

------

**Item 1.**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Name of Issuer

Context Therapeutics Inc. (the "Issuer")

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Address of Issuer's Principal Executive Offices

2001 Market Street, Suite 3915, Unit #15<br>Philadelphia, Pennsylvania 19103

**Item 2.**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Name of Person Filing

This Schedule 13G is being filed by Martin Lehr, the Martin Lehr 2000 Trust and Ellyn Lehr.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Address of Principal Business Office or, if none, Residence

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Martin Lehr: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2001 Market Street, Suite 3915, Unit #15

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Philadelphia, Pennsylvania 19103

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Martin Lehr 2000 Trust: &nbsp;&nbsp;&nbsp;&nbsp;2001 Market Street, Suite 3915, Unit #15

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Philadelphia, Pennsylvania 19103

&nbsp;&nbsp;&nbsp;&nbsp; (iii) Ellyn Lehr: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2001 Market Street, Suite 3915, Unit #15

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Philadelphia, Pennsylvania 19103

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Citizenship

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Martin Lehr: United States

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Martin Lehr 2000 Trust: Pennsylvania

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Ellyn Lehr: United States

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Title of Class of Securities

Common stock, par value $0.001 per share

&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;CUSIP Number

21077P108

**Item 3.**&nbsp;&nbsp;&nbsp;&nbsp;**If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;Broker or dealer registered under section 15 of the Act.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;Bank as defined in section 3(a)(6) of the Act.

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;Insurance company as defined in section 3(a)(19) of the Act.

&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;Investment company registered under section 8 of the Investment Company Act of 1940.

&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E).

&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F).

&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G).

&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.

------

&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940.

&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J).

&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

**Item 4.**&nbsp;&nbsp;&nbsp;&nbsp;**Ownership**

&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;Amount Beneficially Owned

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Martin Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,186,102 shares\*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Martin Lehr 2000 Trust: &nbsp;&nbsp;&nbsp;&nbsp;820,190 shares\*\*

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Ellyn Lehr: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;820,190 shares\*\*

\* Consists of (i) 820,190 shares of the Issuer's common stock held by the Martin Lehr 2000 Trust, (ii) 243,329 shares of the Issuer's common stock underlying options held directly by Mr. Lehr that are exercisable within 60 days of December 31, 2022 (the "Option Shares") and (iii) 122,583 shares of the Issuer's common stock held directly by Mr. Lehr.

\*\* Represents shares of the Issuer's common stock held by the Martin Lehr 2000 Trust.

&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Percent of Class

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Martin Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Martin Lehr 2000 Trust: &nbsp;&nbsp;&nbsp;&nbsp;5.1%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Ellyn Lehr: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.1%

Based upon 15,966,053 shares of the Issuer's common stock outstanding as of November 4, 2022, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2022, plus, in the case of Mr. Lehr, the Option Shares.

&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Number of shares as to which such person has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &nbsp;&nbsp;&nbsp;&nbsp;Sole power to vote or to direct the vote

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Martin Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;365,912

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Martin Lehr 2000 Trust:&nbsp;&nbsp;&nbsp;&nbsp;0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) Ellyn Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) &nbsp;&nbsp;&nbsp;&nbsp; Shared power to vote or to direct the vote

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Martin Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;820,190

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Martin Lehr 2000 Trust:&nbsp;&nbsp;&nbsp;&nbsp;820,190

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) Ellyn Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;820,190

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Sole power to dispose or to direct the disposition of

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Martin Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;365,912

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Martin Lehr 2000 Trust:&nbsp;&nbsp;&nbsp;&nbsp;0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) Ellyn Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) &nbsp;&nbsp;&nbsp;&nbsp;Shared power to dispose or to direct the disposition of

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Martin Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;820,190

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Martin Lehr 2000 Trust:&nbsp;&nbsp;&nbsp;&nbsp;820,190

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) Ellyn Lehr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;820,190

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Ownership of Five Percent or Less of a Class**

&nbsp;&nbsp;&nbsp;&nbsp;If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following .

Not Applicable

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Ownership of More than Five Percent on Behalf of Another Person.**

&nbsp;&nbsp;&nbsp;&nbsp;Not Applicable

**Item 7.&nbsp;&nbsp;&nbsp;&nbsp;Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person**

Not Applicable

**Item 8.&nbsp;&nbsp;&nbsp;&nbsp;Identification and Classification of Members of the Group**

Not Applicable

**Item 9.&nbsp;&nbsp;&nbsp;&nbsp;Notice of Dissolution of Group**

Not Applicable

**Item 10.&nbsp;&nbsp;&nbsp;&nbsp;Certification**

Not Applicable

------

**SIGNATURE**

&nbsp;&nbsp;&nbsp;&nbsp;After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth

in this statement is true, complete and correct.

Date:&nbsp;&nbsp;&nbsp;&nbsp;February 14, 2023

MARTIN LEHR

By: <u>/s/ Martin Lehr&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name: Martin Lehr

MARTIN LEHR 2000 TRUST

By: <u>/s/ Ellyn Lehr&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name: Ellyn Lehr

Title: Trustee

ELLYN LEHR

By: <u>/s/ Ellyn Lehr&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

Name: Ellyn Lehr

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| **<u>Exhibit Number</u>** | **<u>Exhibit</u>** |
| 99.1 | Joint Filing Agreement, dated February 14, 2023, by and among Martin Lehr, the Martin Lehr 2000 Trust and Ellyn Lehr |

---

------

**Exhibit 99.1**

**JOINT FILING AGREEMENT**

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to certain shares of the common stock of Context Therapeutics Inc. and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filing.

The undersigned further agree that each party hereto is responsible for the timely filing of such Schedule 13G and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein; provided, however, that no party is responsible for the completeness or accuracy of the information concerning any other party making the filing, unless such party knows or has reason to believe that such information is inaccurate.

IN WITNESS WHEREOF, the parties have executed this Joint Filing Agreement as of February 14, 2023.

---

| | |
|:---|:---|
| By: | /s/ Martin Lehr |
|  | Martin Lehr |
| MARTIN LEHR 2000 TRUST | MARTIN LEHR 2000 TRUST |
| By: | /s/ Ellyn Lehr |
|  | Ellyn Lehr, Trustee |
| By: | /s/ Ellyn Lehr |
|  | Ellyn Lehr |

---

<br>